The binding of beta 2-glycoprotein-I to human serum lipoproteins: distribution among density fractions
about
High affinity binding of beta 2-glycoprotein I to human endothelial cells is mediated by annexin IIPlasmin-cleaved beta-2-glycoprotein 1 is an inhibitor of angiogenesisAnti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H)T cells that are autoreactive to beta2-glycoprotein I in patients with antiphospholipid syndrome and healthy individualsPlasma lipopolysaccharide-binding protein is found associated with a particle containing apolipoprotein A-I, phospholipid, and factor H-related proteinsThe epitopes for some antiphospholipid antibodies are adducts of oxidized phospholipid and beta2 glycoprotein 1 (and other proteins)Simvastatin Efficiently Lowers Small LDL-IgG Immune Complex Levels: A Therapeutic Quality beyond the Lipid-Lowering EffectImpaired thrombin generation in beta 2-glycoprotein I null miceAssociation of beta2-glycoprotein I IgG and IgM antibodies with thrombosis and thrombocytopenia.Functional and genetic characterization of the promoter region of apolipoprotein H (beta2-glycoprotein I)Accelerated atheroma and anti-beta2-glycoprotein I antibodies.beta2-glycoprotein i is a cofactor for tissue plasminogen activator-mediated plasminogen activationGenetic studies of human apolipoproteins. IV. Structural heterogeneity of apolipoprotein H (beta 2-glycoprotein I)Interactions between Hepatitis C Virus and the Human Apolipoprotein H Acute Phase Protein: A Tool for a Sensitive Detection of the VirusAssociation of the Trp316Ser variant (rs1801690) near the apolipoprotein H (β2-glycoprotein-I) gene and serum lipid levelsβ2-Glycoprotein I Inhibits Vascular Endothelial Growth Factor-Induced Angiogenesis by Suppressing the Phosphorylation of Extracellular Signal-Regulated Kinase 1/2, Akt, and Endothelial Nitric Oxide Synthase.Identification of a region of beta 2-glycoprotein I critical for lipid binding and anti-cardiolipin antibody cofactor activityComplete amino acid sequence of human plasma beta 2-glycoprotein I.Liposome opsonization.Small β2-glycoprotein I peptides protect from intestinal ischemia reperfusion injury.Recombinant hepatitis B surface antigen and anionic phospholipids share a binding region in the fifth domain of beta2-glycoprotein I (apolipoprotein H)Hepatitis B virus surface antigen binds to apolipoprotein H.Targeted Proteomics Identifies Paraoxonase/Arylesterase 1 (PON1) and Apolipoprotein Cs as Potential Risk Factors for Hypoalphalipoproteinemia in Diabetic Subjects Treated with Fenofibrate and Rosiglitazone.Antiphospholipid antibodies: effects on trophoblast and endothelial cells.Human plasma protein N-glycosylationComprehensive evaluation of apolipoprotein H gene (APOH) variation identifies novel associations with measures of lipid metabolism in GENOA.Beta 2-Glycoprotein I binds factor XI and inhibits its activation by thrombin and factor XIIa: loss of inhibition by clipped beta 2-glycoprotein I.Beta 2-glycoprotein-1 (apolipoprotein H) excretion in chronic renal tubular disorders: comparison with other protein markers of tubular malfunctionbeta2-glycoprotein-I (apolipoprotein H) and beta2-glycoprotein-I-phospholipid complex harbor a recognition site for the endocytic receptor megalin.Beta-2-glycoprotein 1-dependent macrophage uptake of apoptotic cells. Binding to lipoprotein receptor-related protein receptor family members.Molecular studies on phospholipid-binding sites and cryptic epitopes appearing on beta 2-glycoprotein I structure recognized by anticardiolipin antibodies.Cloning and characterization of the human beta2-glycoprotein I (beta2-GPI) gene promoter: roles of the atypical TATA box and hepatic nuclear factor-1alpha in regulating beta2-GPI promoter activityExpression of anticardiolipin cofactor, human beta 2-glycoprotein I, by a recombinant baculovirus/insect cell system.Complete nucleotide and deduced amino acid sequence of human beta 2-glycoprotein I.Characterization of binding of human beta 2-glycoprotein I to cardiolipin.Isolation from fetal bovine serum of an apolipoprotein-H-like protein which inhibits thymidine incorporation in fetal calf erythroid cells.Heparin-binding apoproteins. Effects on lipoprotein lipase and hepatic uptake of remnants.Binding of plasma proteins to titanium dioxide nanotubes with different diameters.Membrane binding of beta2-glycoprotein I can be described by a two-state reaction model: an atomic force microscopy and surface plasmon resonance study.Omega-carboxyl variants of 7-ketocholesteryl esters are ligands for beta(2)-glycoprotein I and mediate antibody-dependent uptake of oxidized LDL by macrophages.
P2860
Q22254095-4593B07D-5EA1-4D83-95A0-19B078CB40DBQ24293734-5CD41FED-6D75-4311-8D24-2D0D1F7BB483Q24558202-79620C03-516A-41A6-BF4F-0F628935C0B8Q28143036-469AFC92-2CE9-4F10-A781-303696462EFAQ28282116-FF9E5259-2265-4014-BF35-B6060E873666Q28379106-36D294DC-D7A7-4D2F-AD60-F337F2BC2CF3Q28553042-1DCB1B7C-BE81-4448-8E16-B4C764F05B83Q28593655-EBFA61D7-5F80-4554-85DE-4D0496482040Q33338788-A4F40F1E-D216-4DAE-8EDC-EE94265814AAQ33815147-96AC138C-D28B-4B2A-B224-4A12D719A995Q33915467-5DEC4035-D64C-41FB-8C18-AEB158C4E0ADQ34245642-47EE609D-3043-4D29-98D4-85A281CB0534Q35245457-A809F380-8C32-44ED-A310-A9B01CDFB818Q35821487-E575A16B-F26B-4E5E-8B15-999519FC2E40Q35919414-C6D5193C-46D1-421B-8C8A-49E09EF83737Q36118474-C74BF2F6-BDBC-4734-9D50-E9AD645D836CQ36157442-42A5D8A7-C875-4482-BA2E-797F2CA3D30AQ36262293-F332ACE1-BB07-4438-9E62-209E0E5785CCQ36272611-8F909D38-7CC8-4EA7-BCEA-4024B9E4D2AAQ36374030-7FEBA58F-F654-4D06-9B6E-6C58E0CA17B2Q36596956-2DC68AC6-EB60-4E70-9756-0A398597E5F7Q36632110-38C35323-2350-4EB1-8C79-6EB011630650Q36745091-6CEB279B-C3F8-4A50-BB13-C9A3244D22D3Q36881604-28F29BB9-D31F-4DFB-9CC8-173BF87017B0Q36963945-33D0D6F3-5F7A-409F-934E-33CE1BAFB298Q36971284-EBB25B84-CD37-41A6-9CAB-D7A88AC5D9D1Q37095385-534FDF8F-E919-4A37-8272-E88A78A202CCQ37138485-50E3C091-E232-48E5-9E5C-258124A4CE83Q39808627-70E13617-EF6D-4763-96B0-EFEA1C06EBE5Q40036677-AD8C9142-61C5-447F-A6CC-40C0FD6051CFQ40400869-C9E6F080-7608-4C62-A629-DE28428DDD25Q40585799-7E1913A2-CC85-4DC6-83EE-C1F14E7FB215Q41545004-40EE61CE-8074-42F2-B26D-1A93C7A4E14DQ41674799-6EE78FBD-D2CF-4F43-A93E-F87B8F90E75EQ41921283-025B3CD4-5ED2-4082-9F55-E55DFCAD9AE7Q42069022-794A74BE-5CA4-48E7-B289-880976CB1358Q42099603-F9027826-3CC4-466A-B4BB-82127C5BFBC1Q42151289-A625F4CC-9137-425E-804B-304F6EFE6169Q42928356-4556B567-7702-49EB-95F1-316F5602C1F2Q44138798-D0F434E1-D44D-404A-A8D0-CB8B9DE79523
P2860
The binding of beta 2-glycoprotein-I to human serum lipoproteins: distribution among density fractions
description
1979 nî lūn-bûn
@nan
1979 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1979 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1979年の論文
@ja
1979年論文
@yue
1979年論文
@zh-hant
1979年論文
@zh-hk
1979年論文
@zh-mo
1979年論文
@zh-tw
1979年论文
@wuu
name
The binding of beta 2-glycopro ...... bution among density fractions
@ast
The binding of beta 2-glycopro ...... bution among density fractions
@en
The binding of beta 2-glycopro ...... bution among density fractions
@nl
type
label
The binding of beta 2-glycopro ...... bution among density fractions
@ast
The binding of beta 2-glycopro ...... bution among density fractions
@en
The binding of beta 2-glycopro ...... bution among density fractions
@nl
prefLabel
The binding of beta 2-glycopro ...... bution among density fractions
@ast
The binding of beta 2-glycopro ...... bution among density fractions
@en
The binding of beta 2-glycopro ...... bution among density fractions
@nl
P2860
P3181
P1433
P1476
The binding of beta 2-glycopro ...... bution among density fractions
@en
P2093
P2860
P3181
P356
10.1016/0014-5793(79)80955-2
P407
P577
1979-06-01T00:00:00Z